Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 3, 2009, Pages 345-346

  Gidwani, Kamlesh ^a   Kumar, Rajiv ^a   Rai, Madhukar ^a   Sundar, Shyam ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTINATION TEST; ARTICLE; EPIDEMIOLOGY; HUMAN; INDIA; SEROPREVALENCE; VISCERAL LEISHMANIASIS;

EID: 62949165693     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.345     Document Type: Article

References (16)

1. Desjeux P, 2004. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305-318.
2. Desjeux P, 1992. Human leishmaniases: epidemiology and public health aspects. World Health Stat Q 45:267-275.
3. Bora D, 1999. Epidemiology of visceral leishmaniasis in India. Natl Med J India 72:62-68.
4. Costa CH, Stewart JM, Gomes RB, Garcez LM, Ramos PK, Bozza M, Satoskar A, Dissanayake S, Santos RS, Silva MR, Shaw JJ, David JR, Maguire JH, 2002. Asymptomatic human carriers of Leishmania chagasi. Am J Trop Med Hyg 66:334-337.
5. Singh S, Kumar V, Singh N, 2002. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Clinical 9: 568-572.
6. Sinha PK, Bimal S, Pandey K, Singh SK, Ranjan A, Kumar N, Lai CS, Barman SB, Verma RB, Jeyakumar A, Das P, Bhattacharya M, Sur D, Bhattacharya SK, 2008. A community-based, comparative evaluation of direct agglutination and rK39 strip tests in the early detection of subclinical Leishmania donovani infection. Ann Trop Med Parasitol 102:119-125.
7. Zijlstra EE, Ali MS, el-Hassan AM, el-Toum IA, Satti M, Ghalib HW, Kager PA, 1991. Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan. Trans R Soc Trop Med Hyg 85:474-476.
8. Singla N, Singh GS, Sundar S, Vinayak VK, 1993. Evaluation of the direct agglutination test as an immunodiagnostic tool for kala- azar in India. Trans R Soc Trop Med Hyg 87: 276-278.
9. Sundar S, Reed SG, Singh VP, Kumar PC, Murray HW, 1998. Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet 351:563-565.
10. Sundar S, Sahu M, Mehta H, Gupta A, Kohli U, Rai M, Berman JD, Murray HW, 2002. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit. Clin Infect Dis 35: 581-586.
11. Harith AE, Kolk AH, Kager PA, Leeuwenburg J, Faber FJ, Muigai R, Kiugu S, Laarman JJ, 1987. Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA. Trans R Soc Trop Med Hyg 81: 603-606.
12. Bern QHightowerAW,ChowdhuryR,Ali M,AmannJ,Wagatsuma Y, Haque R, Kurkjian K, Vaz LE, Begum M, Akter T, Cetre- Sossah CB, Ahluwalia IB, Dotson E, Secor WE, Breiman RF, Maguire JH, 2005. Risk factors for kala-azar in Bangladesh. Emerg Infect Dis 11: 655-662.
13. Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A,Teixeira R, Johnson WD Jr, 1986. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 154: 1003-1011.
14. Le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelieure A, Marty P, Suffia I, Rousseau D, Kubar J, 1999. Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol 37: 1953-1957.
15. Bucheton B, Abel L, El-Safi S, Kheir MM, Pavek S, Lemainque A, Dessein AJ, 2003. A major susceptibility locus on chromosome 22ql2 plays a critical role in the control of kala-azar. Am J Hum Genet 73:1052-1060.
16. Mohamed HS, Ibrahim ME, Miller EN, White JK, Cordell HJ, Howson JM, Peacock CS, Khalil EA, Elhassan AM, Blackwell JM,2004. SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. Eur J Hum Genet 12: 66-74.